Celltrion confident in quality of biosimilar supply despite US FDA 483
Celltrion Inc has received a FDA Form 483 with 12 observations but remains confident no exported biosimilar products have any quality issues.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs